The imprinted domain on human chromosome 15 consists of two oppositely imprinted gene clusters, which are under the coordinated control of an imprinting center (IC) at the 5′ end of the SNURF-SNRPN gene. One gene cluster spans the centromeric part of this domain and contains several genes that are transcribed from the paternal chromosome only (MKRN3, MAGEL2, NDN, SNURF-SNRPN, HBII-13, HBII-85 and HBII-52). Apart from the HBII small nucleolar RNA (snoRNA) genes, each of these genes is associated with a 5′ differentially methylated region (DMR). The second gene cluster maps to the telomeric part of the imprinted domain and contains two genes (UBE3A and ATP10C), which in some tissues are preferentially expressed from the maternal chromosome. So far, no DMR has been identified at these loci. Instead, maternal-only expression of UBE3A may be regulated indirectly through a paternally expressed antisense transcript. We report here that a processed antisense transcript of UBE3A starts at the IC. The SNURF-SNRPN sense/ UBE3A antisense transcription unit spans more than 460 kb and contains at least 148 exons, including the previously identified IPW exons. It serves as the host for the previously identified HBII-13, HBII-85 and HBII-52 snoRNAs as well as for four additional snoRNAs (HBII-436, HBII-437, HBII-438A and HBII-438B), newly identified in this study. Almost all of those snoRNAs are encoded within introns of this large transcript. Northern blot analysis indicates that most if not all of these snoRNAs are indeed expressed by processing from these introns. As we have not obtained any evidence for other genes in this region, which, from the mouse data appears to be critical for the neonatal Prader-Willi syndrome phenotype, a lack of these snoRNAs may be causally involved in this disease.
INTRODUCTION
In contrast to most other genes, imprinted genes are differentially expressed from the maternal and paternal allele. Imprinted gene expression can occur in all cells of an individual or in a temporally and spatially restricted manner. Whereas maternal silencing most often involves promoter methylation, paternal silencing does so less often. It has been argued that this is the evolutionary result of early epigenetic reprogramming in the zygote (1) . As the paternal genome is actively demethylated in the oocyte, it may have developed other strategies to silence genes. One such strategy may be the expression of an antisense transcript, which indirectly silences the paternal allele. In fact, all antisense transcripts identified within imprinted regions so far are expressed from the paternal allele only, apart from Tsix (2) . However, it is still unknown how an antisense transcript might silence a gene in cis. Whatever mechanism is involved in this process, indirect silencing through an antisense transcript may make gene expression amenable to temporal and spatial modulation.
A suitable system to study the regulation of imprinted gene expression is the Prader-Willi/Angelman syndrome (PWS/AS) region on human chromosome 15 (reviewed in 3). This region is under the coordinated control of an imprinting center (IC) at the 5′ end of the SNURF-SNRPN gene (4, 5) , which is expressed from the paternal allele in all tissues studied so far. SNURF-SNRPN and other paternally expressed genes in this region are associated with a differentially methylated region (DMR). In contrast, two genes located telomeric to SNURF-SNRPN (UBE3A and ATP10C) are imprinted in the opposite direction, and imprinted expression is restricted to certain tissues (6) (7) (8) (9) . Whereas SNURF-SNRPN is transcribed from centromere to telomere, UBE3A and ATP10C are transcribed from telomere to centromere.
Recently it has been reported that UBE3A was methylated in a monochromosomal hybrid cell line containing a paternal human chromosome 15, but unmethylated in a cell line containing a maternal chromosome 15, although the gene was expressed in both cell lines (10) . However, systematic investigations by several labs have so far failed to detect a DMR at this locus in human tissues (11, A.C.Lossie and D.J.Driscoll, personal communication; unpublished data). On the other hand, a paternally expressed and intronless UBE3A antisense RNA fragment of ∼20 kb has been detected by Rougeulle et al. (12) . In the mouse, Chamberlain et al. (13) have demonstrated that this antisense transcript is under the control of the IC: in a mouse harboring an IC deletion on the paternal chromosome, the antisense transcript was absent and Ube3a was expressed biallelically in brain. However, it remained unclear, whether the antisense transcript was directly or indirectly controlled by the IC. Here we show that the antisense transcript starts at the IC.
Whereas UBE3A has been identified as the AS gene (14, 15) , the genes involved in PWS are less clear. Mouse data suggest that the region between SNURF-SNRPN and IPW may be critical. We have recently shown that this region encodes multiple copies of small nucleolar RNAs (snoRNAs) HBII-13, HBII-85 and HBII-52 (16) . HBII-85 gene copies have also been described by de los Santos et al. (17) and Meguro et al. (10) . Whereas the HBII-13 snoRNA is present as a single gene, HBII-85 and HBII-52 are present in 24 or 47 gene copies, respectively. Here we show that the SNURF-SNRPN sense/UBE3A antisense transcription unit serves as the host gene for these snoRNAs as well as for four newly identified candidates for snoRNAs, HBII-436, HBII-437, HBII-438 A and HBII-438B.
RESULTS

The SNURF-SNRPN transcription unit
Recently, we identified eight novel non-coding 3′ exons of the SNURF-SNRPN gene (exons [13] [14] [15] [16] [17] [18] [19] [20] (18) . Based on RT-PCR experiments, EST and UniGene cluster sequence data exon 20 appeared to be 15.8 kb in length, but it was unclear whether it was the true 3′ end of the SNURF-SNRPN transcription unit. We could not exclude at this point that this exon might contain an alternative splice donor site giving rise to a variant transcript extending much further. A similar situation had been encountered at exons 12 and 16 (18) . To address this question, we searched for ESTs between exon 20 and the UBE3A locus. Using the sequence of the overlapping genomic BAC/PAC clones RP11-131I21, A17157+P0950, RP13-487P22 and pDJ373b1 (GenBank accession nos. AC009696.10, AF250841, AC084009 and AC004600) and the NIX software (http:// www.hgmp.mrc.ac.uk/), we identified two EST clusters, one containing IPW sequences and another one covering most of the UBE3A gene in an antisense orientation to the latter gene. Both EST clusters contained spliced exons. By complete sequencing of six EST clones of the first cluster (AI968076, AI990296, AI638004, AW237252, R11106 and AI672541) and two RT-PCR products from human fetal brain RNA (RT-3 and RT-4; Fig. 1A ), we identified 23 novel exons representing six different alternatively spliced variants of one transcript. This transcript includes IPW exons 1-3, which also were found to be subject to alternative splicing. The EST cluster in the UBE3A region comprises five overlapping ESTs with distinct spliced exons. We sequenced three of these cDNA clones (N52596, R19540 and W90408/W90381) and found 11 novel exons in three different alternatively spliced isoforms. The four most downstream exons were found to cover most of UBE3A in an antisense manner with one exon between UBE3A exon 1 and 2, one between exon 7 and 8 and another one which overlaps with the UBE3A 3′ region (Fig.  1C) .
By screening a human adult kidney cDNA library selected for large inserts with RT-PCR products for the IPW and UBE3A regions (RT-3 and RT-18), we obtained 16 cDNA clones from 1 to 4.9 kb (kid1-16) for the IPW region and one cDNA clone of 6.1 kb (kid17) for the UBE3A region. By complete sequencing of 8 cDNA clones, we identified 46 additional exons, 14 for the IPW and 32 for the UBE3A region ( Fig. 1A and C) . Interestingly, these exons map inside the previously reported snoRNA gene clusters HBII-85 and HBII-52.
To find out whether all these exons belong to the SNURF-SNRPN transcription unit or are part of independent transcripts we searched for additional exons and tried to connect SNURF-SNRPN exon 20 with the HBII-85/IPW and the HBII-52/ UBE3A exon clusters, respectively. For this purpose, we made use of the high sequence similarity of the exons inside the HBII-52 and the HBII-85 gene clusters and searched for more or less conserved splice donor and splice acceptor sites to predict putative exons for primer design. In fact, by extended exon-connection RT-PCR on human fetal brain RNA, we identified additional exons and could eventually link the SNURF-SNRPN 3′ exons with the exon cluster in the HBII-85/ IPW region and in turn connect the IPW exons with the exons in the HBII-52/UBE3A region ( Fig. 1A and B) . Thereby we detected a splice donor site at nucleotide position 162 of exon 20. But, based on EST sequences of three ESTs (AI197860, BF672929 and AW294767) and RT-PCRs on DNaseI-treated RNA from fetal brain at seven different sites (data not shown), we found also that >30 kb of DNA contiguous with exon 20 is expressed as RNA (Fig. 1D) .
Similarly to this situation, exon 61 (IPW exon 3) contains alternative splice donor and acceptor sites (Fig. 1D) . Again, based on sequence data for some of the kidney cDNA clones, EST sequences of 18 ESTs (AI792942, AW299520, AW779767, N21972, AW893968, H63591, H85187, AW973432, H17549, AI537107, AV709519, AA001781, BF796272, AA719946, BF315994, AL719946, BF315994, AL137489) and RT-PCRs on DNaseI-treated RNA from fetal brain at five different sites, we found that >50 kb of DNA contiguous with exon 61 is expressed as RNA (data not shown; Fig. 1D ).
In summary, we have identified 128 novel exons of the SNURF-SNRPN transcription unit. As for the previously reported 3′ exons 10-20 we could not find any significant open reading frame. Based on the cDNA clone kid17, there is at least one putative 3′ end in exon 146 with a polyadenylation site 21 nt upstream of a poly(A) tail.
Expression analysis
Northern blots containing poly(A)+ RNA from 16 different adult and four fetal tissues (Clontech) were hybridized with two different probes (RT-PCR products RT-3 and RT-18), representing exons 42, 43, 44, 46 and 138-142. Both probes failed to detect a distinct signal (data not shown). However, from EST sequences, cDNA clones and RT-PCR experiments, this transcript is expressed in various tissues. To investigate the imprinting status of the novel exons, we performed RT-PCR with primers AI990296 a and b (RT-3, exons 42, 43, 44, 46) and MRts 5-6F and R (RT-17, exons 141-142). As a template we used lymphoblastoid cell line RNA from a patient with AS and a maternal deletion of 15q11-q13 and a patient with PWS and a paternal deletion of this region. As shown in Figure 2 , two RT-PCR products of the expected sizes of 501 and 120 bp, respectively, were obtained from the AS RNA, but not from the PWS RNA. These data indicate that these exons are expressed from the paternal chromosome only. This is in agreement with previously reported paternal only expression of the IPW exons, which we found to be part of the transcript unit.
To substantiate the notion that the newly identified exons are part of the SNURF-SNRPN transcription unit, we used the same primer pairs to investigate expression in a patient with a de novo translocation t(X;15)(q28;q12). In this patient, the 15q breakpoint is between exons 20a and 21. As previously shown for the IPW exons (18) which map between the two regions tested here, no expression was observed (Fig. 2) .
Novel paternally expressed C/D box snoRNAs in the PWS/ AS region
By computer aided analysis, using conserved sequence and structural motifs, we have identified four novel candidates for C/D box snoRNAs distal to SNURF-SNRPN, designated HBII-436, HBII-437, HBII-438A and HBII-438B (Fig. 3A) . With one exception (HBII-437) the sequences contain all the sequence (C-, C′-, D′-and D-boxes) and structural motifs (short inverted repeats at their 5′-and 3′ ends) of bona fide C/D box snoRNAs. HBII-437 was found to contain a degenerate D-box: GTGA instead of CTGA, making it a less likely candidate for a bona fide snoRNA. HBII-436 maps ∼3.5 kb proximal whereas HBII-437 maps ∼0.9 kb distal to the HBII-13 snoRNA, inside the PAR-SN/PAR-5 region. With regard to the SNURF-SNRPN transcription unit, all three map inside intron 12. HBII-438A and HBII-438B are identical in sequence, but are located ∼240 kb apart with one copy located within intron 20a of SNURF-SNRPN just proximal to the HBII-85 gene cluster, and the second copy within intron 143, just distal to the HBII-52 gene cluster.
We have analyzed the tissue-specific expression of HBII-436, HBII-437, HBII-438A and HBII-438B by northern blot analysis containing total RNA of human brain, liver, muscle, lung, kidney and heart (Fig. 3B) . HBII-436 is expressed in brain, lung and kidney and, to a lower extent, in muscle and heart. After longer exposure of autoradiograms, expression in liver is also observed. The expression pattern closely resembles that of the recently described C/D box snoRNA HBII-13, which maps close to HBII-436 (16) . The expression pattern of HBII-438A and HBII-438B cannot be tested independently, since both sequences are identical. Their expression pattern resembles that of HBII-85, e.g. strongest expression in brain and kidney, weaker expression in muscle and lung and very low expression in liver and heart (Fig. 3B) . HBII-436 and HBII-438A and/or B are paternally expressed, imprinted snoRNAs, since they are not expressed in the brain of a PWS patient, but in the brain of an AS patient (Fig. 3C ). The expression of HBII-437, which harbors a degenerate D-box (see above), could not be confirmed by northern blot analysis using three different oligonucleotides as probes which were derived from the HBII-437 sequence (data not shown).
Expression of the HBII-85 gene and HBII-52 gene copies
We have previously identified 24 copies of the HBII-85 snoRNA species (16) . Additionally, three copies (copies 24, 25 and 26; Fig. 3A ) containing variant, but clearly related species to the HBII-85 snoRNA could be found in our screen. A sequence alignment of all 27 gene copies revealed that three main paralogous groups of HBII-85 exist in the genome (Fig. 4A ). Group I consists of gene copies 1-9, which is followed by Group II encoding copies 10-23 and Group III (copies 24-27) containing four degenerate copies, which map to the telomeric end of the HBII-85 gene cluster.
Canonical snoRNAs targeting ribosomal RNAs for modification contain antisense boxes located immediately 5′ to the D-or D′-box, complementary to distinct regions within rRNAs. By this mechanism 2′-O-methylation of riboses within ribosomal RNA is achieved (reviewed in 19, 20) . Two unusual features can be observed within the antisense boxes of the HBII-85 snoRNA cluster (Fig. 4A) . First, no complementarity to ribosomal RNA modification sites can be found indicative of other RNA targets, like for example mRNAs (16) . Second, sequences of antisense boxes vary between all three groups. Using oligonucleotides specific for some members of each of the three groups (Fig. 4A , red dots), we performed northern blot analysis to determine whether representatives of each group were expressed in human brain. As shown in Figure 4B , this is indeed the case. Furthermore, the expression level of respective RNA species from the three groups, as assessed by northern blot analysis and subsequently quantitated by phosphoimaging, correlated well with their copy number. This is consistent with a model that all (or most) copies of HBII-85 snoRNAs are indeed expressed in human brain.
No clear distinction of groups can be made for the 47 gene copies of the HBII-52 snoRNA cluster, with the exception of three copies (copies [17] [18] [19] , which deviate by three bases from the consensus motif of the antisense box (data not shown). Northern blot analysis using either a consensus oligonucleotide directed against 32 of the 47 copies (Fig. 4C , Group I) or a specifc oligonucleotide directed against the three deviating copies (Fig. 4C , Group II) demonstrates that the three copies were also expressed. As observed for the HBII-85 snoRNA gene cluster, the expression level of the three versus 32 copies, correlated well with their respective copy number (Fig. 4C) .
DISCUSSION
The SNURF-SNRPN locus on human chromosome 15 appears to be one of the most complex loci in the human genome. The core gene has 10 exons, which are transcribed into a 1.4 kb bicistronic mRNA. Whereas exons 1-3 encode the SNURF protein (21), exons 4-10 encode the SmN splicosomal protein (22) . There are at least two alternative 5′ start sites and multiple untranslated upstream exons of unknown function (23, 24) . Furthermore, this locus harbors a bipartite IC, which controls the whole imprinted domain (5, 23, 25, 26) . Whereas the AS IC element, which spans the upstream exon u5, is necessary for maternal imprinting, the PWS IC element, which spans exon 1, is necessary for the postzygotic maintenance of the paternal imprint (27, 28) . We also detected additional 3′ exons of unknown function (18, 29) . Here we describe that the SNURF-SNRPN transcription unit extends much more 3′ and serves two additional functions: (i) it is the host for multiple snoRNA genes and (ii) it serves as the start site for the UBE3A antisense transcript (Fig. 5A) . Although the role of the antisense transcript is unknown, there are some data compatible with the assumption that it may control imprinted expression of UBE3A (12, 13) . So far, we have failed to extend the transcript further downstream, but it is tempting to speculate that it may extend beyond exon 148 to the ATP10C locus and be associated with imprinted expression of this gene as well.
The evidence for a large SNURF-SNRPN sense/UBE3A antisense transcript initiated at the IC is based on the identification of overlapping cDNA clones and RT-PCR products. We have not been able to detect the transcript by northern blot analysis, but this may be due to its large size, low level of expression or unstable nature and the presence of multiple alternative splice forms. The evidence for this transcript is supported, although not proven, by three observations. (i) As shown by expression analysis in a patient with a balanced reciprocal translocation X;15 (18) , exons distal to the translocation breakpoint are not expressed. (ii) In the mouse, a deletion of exon 1 on the paternal chromosome results in lack of expression of the UBE3A antisense transcript (13). (iii) There are no predicted CpG islands or other putative transcriptional start sites between SNURF-SNRPN and UBE3A (Buiting et al., unpublished) . This also suggests that there is no other gene in between, apart from the snoRNA genes (see below).
Although evidence for a UBE3A antisense RNA in humans and mice has been obtained before (12, 13) , both papers describe only short fragments that are colinear with genomic DNA. It is likely that the human antisense fragment detected Table 1 . RT-PCR products and primer sequences a Due to the high sequence similarity of the HBII-52 repeats, primer cPCR19R.2 and cPCR6R did not anneal to their complementary sequence, and RT-8 and RT-12 resulted from mispriming.
RT-PCR
RT-PCR primer pairs Primer sequences (5′-3′ orientation)
RT-16 MRts2-9F TATGGAAGAAAAGCACTCTTTGG
MRts2-9R CAAAGTCTCCCCTTCGTGTT
RT-17 MRts5-6F GGCACTGAAAATGTGGCATCCAGTC
MRts5-6R GGTGTGTCAGCTGTGCTGGTGTCAA
RT-18
MRts2-6F CACTCTTTGGCCTGTTGTGA
MRts2-6R GTGTCAGCTGTGCTGGTGTC
RT-19 MRts8-9F AAGGCCTGGAATCTGATCCT
MRts8-9R CCTAGATTTTAAATAGACAATCCAAAG
RT-20
MRts10-11F AGAAAAGGCGCAATGAAAGA (2, 30) . It is unclear how the antisense transcript might regulate UBE3A expression in cis. However, well established mechanisms such as tissue-specific RNA splicing may generate different isoforms of the antisense transcript, which may or may not silence UBE3A. This may explain the observation that UBE3A is expressed from both alleles in certain tissues and preferentially from the maternal allele in others.
MRts10-11R TTGGCAAGGAGAGCTTGTCT
Our findings have important implications for understanding the function of the 15q IC. The data suggest that there is a functional correlation between the regulation and the spatial organization of the paternally expressed genes and the maternally expressed genes. Imprinted expression of the paternally expressed genes, which are located upstream of the IC, is regulated by domain-wide differential DNA methylation, which is set by the IC. Imprinted expression of the maternally expressed genes, which are located downstream of the IC, may be regulated through a paternally expressed antisense transcript, which is initiated at the IC. In this model (Fig. 5B) , the SNURF-SNRPN gene is the master gene, which has acquired two different mechanisms to control genes located 5′ and 3′ to it. The model predicts that most of the imprinted domain is transcriptionally open on the paternal chromosome and closed on the maternal chromosome. In fact, most of the imprinted domain replicates early at S phase (31, 32) . We are aware that the replication timing data do not necessarily support the model shown in Figure 5B and that other models are conceivable.
Three C/D box snoRNA genes, HBII-13, HBII-85 and HBII-52 have been previously mapped to the region between SNURF-SNRPN and UBE3A (16) . Here we report on four additional candidates for C/D box snoRNA genes. Three of the four novel snoRNA genes, HBII-436, HBII-438A and HBII-438B, were found to be expressed in different tissues with predominant expression in brain and are subject to imprinting. HBII-438A and HBII-438B are identical in sequence, but map ∼240 kb apart from each other within the PWS/AS region. Their conserved sequences give additional support for a proposed functional role of these snoRNAs. The fourth novel candidate snoRNA, HBII-437, which was not detected by northern blot analysis, contains a degenerate D-box. It has been shown previously, that the C-and D-box of C/D-box snoRNAs are essential for processing, stability and function of these molecules (33) (34) (35) . Accordingly, a mutation within the D-box would render the snoRNA instable and subject to rapid degradation by cellular RNases.
In mammals, most snoRNAs known to date are processed from introns of host genes by splicing and subsequent exonucleolytic cleavage (34,35, reviewed in 36,37) . The fact, that all but a few of the snoRNA genes lie within introns of the SNURF-SNRPN sense/UBE3A antisense transcription unit indicates that it serves as the host for these snoRNA genes and that these RNA molecules are indeed processed from this transcription unit. For snoRNA genes HBII-85 and HBII-52, which are present in multiple copies (27 and 47, respectively) in the genome, it is not possible to confirm the expression of single copies. However, since in the case of HBII-85 the different copies from this gene cluster can be assigned to three distinct groups differing in sequence, we were able to confirm the expression of at least one member of each group by northern blot analysis. Since the expression level of different groups correlated well with their respective copy number (Fig. 4B) , it is likely that most, if not all, copies from the HBII-85 cluster are expressed. Similar data were obtained for the HBII-52 snoRNA gene cluster (Fig. 4C) .
Although one copy of the snoRNA HBII-85 genes and two of the HBII-52 genes were found to lie in exons of the transcription unit, we cannot exclude that these copies map inside intronic sequences of yet undetected spliced isoforms of the transcripts as found for other copies of the two snoRNA gene clusters. On the other hand, intron 12, 34, 39 and 99 contain more than one snoRNA gene each. So far, only the presence of a single snoRNA gene per intron has been reported in the literature. Therefore, this suggests that there may be additional, not yet detected exons between the snoRNA copies or alternatively that multiple snoRNAs can be processed from a single intron.
In the case of the HBII-85 and, less so, the HBII-52 snoRNA gene clusters, sequences of antisense elements complementary to a potential RNA target differ between the respective copies of one cluster (Fig. 3A and data not shown) . Therefore, two possibilities can be envisioned. First, only some of the snoRNA copies may have an actual RNA target, whereas the others are not functional. Alternatively, all copies are functional by being directed against different RNA targets. Currently we are employing bio-computational as well as biological approaches to identify potential targets for these RNAs.
Data from mouse models suggest that a paternal deletion from Snrpn to Ube3a causes hypotonia, growth retardation and partial lethality (38) . This suggests the presence in this interval of a gene or genes involved in PWS. Our data indicate that there is no other gene in this interval except for the snoRNA genes, which are encoded within introns of the SNURF-SNRPN sense/UBE3A antisense transcription unit. Specifically, IPW is not an independent gene, but part of this unit. Furthermore, in this region the snoRNA genes appear to be the only conserved entities between mouse and human (unpublished data; 39). This strengthens the hypothesis that loss of the snoRNAs identified by our groups (16, and this work) contributes to PWS. To elucidate the underlying mechanism, it will be of utmost interest to detect their target molecules.
MATERIALS AND METHODS
RNA preparation
Total RNA from human brain, liver, muscle, lung, kidney, heart and lymphoblastoid cell lines was prepared by the trizol method (Gibco/BRL). For RT-PCR experiments, RNA was treated with DNase I to remove residual traces of genomic DNA.
RT-PCR
RT-PCRs were performed with the GeneAmp RNA PCR Kit (Perkin Elmer). Total RNA from brain or lymphoblastoid cell lines (1 µg) was reverse transcribed using random hexamers. The cDNA products were amplified by 35 cycles of PCR.
To determine the expression status of selected gene fragments, we performed RT-PCR with primers which anneal to exons 42 and 46 (RT-3), and primers which anneal to exons 141 and 142 (RT-17; Table 1 ). To check the integrity of the RNA, we used primers for β-actin (40) . In control experiments, reverse transcriptase or cDNA was omitted from the reactions.
Exon-connection PCR was performed on Marathon ready cDNA of human fetal brain or on reverse transcribed human fetal brain RNA (Clontech). PCR products were verified by sequencing with PCR primers. In the case of multiple PCR products, these product were subcloned and sequenced with vector-specific primers. The subset of RT-PCR primers used to amplify a minimal contig of the transcription unit are shown in Table 1 .
Northern blot analysis
For northern blot analysis of the novel exons, human multiple tissue northern blots (Clontech) were hybridized according to the manufacturer's protocol. The final wash was in 2× SSC, 0.1% SDS at 50°C for 10 min. As probes, we used the 501 bp RT-PCR product RT-3 and the 608 bp RT-PCR product RT-18 (Table 1) . To determine the expression and imprinting status of the novel snoRNAs, total RNA was separated on an 8% denaturing polyacrylamide gel (7 M urea, 1× TBE buffer) and transferred onto a nylon membrane (Qiabrane Nylon Plus; Qiagen) using the Bio-Rad semi-dry blotting apparatus (Trans-blot SD; Bio-Rad). After immobilizing of RNAs by the Stratagene crosslinker, the nylon membrane was pre-hybridized for 15 min in 1 M sodium phosphate buffer pH 6.2, 7% SDS. Oligonucleotides complementary to the respective RNA species were end-labeled with 32 P-ATP and T4 polynucleotide kinase; hybridization was carried out at 58°C in 1 M sodium phosphate buffer pH 6.2, 7% SDS for 12 h. A final wash was carried out twice at room temperature for 15 min in 2× SSPE buffer (20 mM sodium phosphate pH 7.4, 0.3 M NaCl, 2 mM EDTA), 0.1% SDS and subsequently for 1 min at 58°C in 0.1× SSPE, 0.5% SDS. Membranes were exposed to Kodak MS-1 film and autoradiographed for 12 h. Oligonucleotides used as probes for the novel snoRNAs are as follows: 5′-AAAT-CATTATGTTCAGACAAGGTCCT-3′ (HB-436), 5′-ACT-CCAGCAAATTACTTTGATCATGA-3′, 5′-TCACGCTC-CCTTTGCAGGAATGG-3′ and 5′-TTTGCAGGAATGG-AAAGTGTCATCC-3′ (HB-437), CAGATTGACATCTG-GAATGAGTCCCTC-5′ (HB-438). For expression studies of the different HBII-85 and HBII-52 gene copies the following oligonucleotides were used: 5′-AAAACTCTATACCGT-CATCCTCGTC-3′ (HBII-85 gene copies 3, 5, 6, 7 and 8), 5′-GAACTCATACCGTCGTTCTCATCG-3′ (HBII-85 gene copies 14-21), 5′-CCAAATCACTTCTGTGCCACTTCTG-3′ (HBII-85 gene copy 24), 5′-CATTCTCAAAAGGATT-ATGC-3′ (HBII-52 gene copies [17] [18] [19] and 5′-CATGCT-CAATAGGATTACGC-3′ (32 gene copies of HBII-52). Quantification of hybridization signals for HBII-85 and HBII-52 snoRNAs was performed by analysis of northern blots on a Fujix BAS 1000 phosphoimager (Fuji) using the Mac BAS V1.0 program.
cDNA clones
EST clones were provided to us from the Resource Centre of the Human Genome Project (RZPD), Berlin. A total of 10 6 phages from a size-selected poly(A)-tailed human adult kidney library (courtesy of L.Schomburg, Hannover, Germany) were screened using probes RT-3 and RT-18. Positive plaques were purified in two rounds. Insert sequences of cDNA clones were determined with vector and sequence-specific primers.
Sequence analysis
RT-PCR products were purified with Microcon-100 microconcentrators (Amicon) or exctracted from agarose gels (Minielute; QIAgen). Sequencing reactions on cDNA clones and RT-PCR products were performed with fluorescencetagged dideoxynucleotides (BIGDye kit) and the Taq cycle sequencing procedure (ABI). Sequences were analyzed on an ABI 3100 DNA Sequencer.
Data deposition
The sequences of a minimal contig of the transcription unit represented by RT-PCR products RT-2I, RT-5, RT-6I, RT-7, RT-8, RT-9, RT-10, RT-11, RT-12, RT-13I, RT-13II, RT-15, RT-16, complete sequence of EST clone R19540 and cDNA clones kid4, kid12, kid16 and kid17 have been deposited in the GenBank database (accession nos AF400485, AF400489, AF400490, AF400491, AF400492, AF400493, AF400494, AF400495, AF400496, AF400497, AF400498, AF400499, AF400500, AF400502, AF400486, AF400487, AF400488 and AF400501, respectively). The GenBank accession nos for the newly identified snoRNAs are AY055806 (HBII-436), AY055807 (HBII-437) and AY055808 (HBII-438A/B).
